4Andersson T, Rohss K, Kassan-Alin M, et al. Pharmacokinetics(PK) and dose-response relationship of esomeprazole [ J ]. Gastroenterology,2000,118(4 Suppl 2) :A 5550. 被引量：1
5[1]Huber R, Kohl B, Sachs G, et al. The continuing development of proton pump inhibitors with particular reference to pantorazole [J]. Aliment Pharmacol Ther , 1995,9:363. 被引量：1
6[2]Blum RA.Lansoprazol and omeprazol in the treatment of acid peptic disorders[J]. Am J Health-Syst Pharm , 1996,53:1401. 被引量：1
7[3]Chiverton SG, Howden CW, Burget DW, et al. Omeprazole (20 mg)daily given in the morning or evening: a comparison of effects on gastric acidity,and plasma gastrin and omeprazole concentration[J] .Aliment Pharmacol Ther,1992,6:103. 被引量：1
8[4]Savarino V, Mela GS, Zentilin P, et al. Variability in individual response to various doses of omeprazole: implication for anti-unlcertherapy[J]. Dig Dis Sci, 1994,39(1):161. 被引量：1
9[5]Bergatrand R.Decreased oral bioavialability of lansoprazole in healthy clunteeres when given with a standardized breakfast[J]. Clin Drug Invest, 1995,9:67. 被引量：1
10[6]Katz PO, Anderson C, Khoury R, et al, Gastro-esophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors[J]. Aliment Pharmacol Ther , 1998,12:1231. 被引量：1
